---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-023202"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2026-05-14T21:27:11+00:00"
generated_at: "2026-05-14T21:28:06.102147+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Glucotrack Q1 net loss $4.3M, IDE submitted to FDA for implantable CGM

## Summary
- Net loss $4.3M vs $6.8M YoY; cash $3.9M as of March 31, 2026.
- Submitted Investigational Device Exemption (IDE) to FDA for fully implantable CBGM; targeting U.S. clinical trial launch in 2H 2026.
- Reduced promissory note from $3.6M to ~$1.6M via stock exchange; drew $1.0M under equity line post-quarter.
- R&D expenses $2.1M, G&A $2.1M; cash runway expected into early 3Q 2026.
- Peer-reviewed data in IEEE Sensors and J. Diabetes Research show sensor stability and 6.8% MARD over 240 days.

## SEC filing metadata
- accession: 0001493152-26-023202
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2026-05-14T21:27:11+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315226023202/0001493152-26-023202-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315226023202/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-023202
- JSON: https://secwatch.observer/filing/0001493152-26-023202.json
- Plain text: https://secwatch.observer/filing/0001493152-26-023202.txt

## Key facts
- Earnings Releases
  Glucotrack, Inc. reported first quarter ended March 31, 2026 results: net income Net loss for the first quarter of 2026 was $4.3 million compared to a net loss of $6.8 million for the first quarter of.
  - Period: first quarter ended March 31, 2026
  - Net income: Net loss for the first quarter of 2026 was $4.3 million compared to a net loss of $6.8 million for the first quarter of
  - Result: reported results
  source text: Net Loss: Net loss for the first quarter of 2026 was $4.3 million compared to a net loss of $6.8 million for the first quarter of 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315226023202/0001493152-26-023202-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.